An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease

Clinical trial NCT02262728 · COMPLETED

Trial details

NCT number

NCT02262728

Sponsor

Janssen Research & Development, LLC

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2014-09-30

Primary completion

2015-08-13

Enrollment

40

View on ClinicalTrials.gov